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In search of potent anti-inflammatory agents, twenty-four chalcone derivatives including seven 
new compounds (13 – 17, 21 and 23) containing pyrrole moiety were designed, synthesized, 
and assessed for their nitric oxide (NO) and prostaglandin E2 (PGE2) suppression ability on IFN-
γ/LPS-induced RAW 264.7 macrophage cells. Results showed that none of the synthesized 
compounds were PAINS-associated molecules, with 3-(2,5-dimethoxyphenyl)-1-(1H-pyrrol-2-yl)-
prop-2-en-1-one (compound 16) exhibiting remarkable inhibition activity towards PGE2 and NO 
production with IC50 values of 0.5 ± 1.5 µM and 12.1 ± 1.5 µM, respectively. Physicochemical 
and ADMET studies showed that majority of the compounds obey to Lipinski's rule of five (RO5) 
having high blood brain barrier (BBB) penetration, human intestinal absorption (HIA), P- 
glycoprotein (PgP) inhibition and plasma binding protein (PPB) inhibition. The obtained atomic 
coordinates for the single-crystal XRD of 16 were then applied in a molecular docking 
simulation, and compound 16 was found to participate in a number of important binding 
interactions in the binding sites of ERK and mPGES-1. Based on these results, we have observed 
the potential of compound 16 as a new hit anti-inflammatory agent, and these findings could 
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